Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21323588rdf:typepubmed:Citationlld:pubmed
pubmed-article:21323588lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C0549473lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C1619635lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C1511876lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C1420708lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:21323588lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:21323588pubmed:issue3lld:pubmed
pubmed-article:21323588pubmed:dateCreated2011-3-7lld:pubmed
pubmed-article:21323588pubmed:abstractTextType I receptor for transferrin (TfR1/CD71) is overexpressed in several malignant tumors, but no studies are available on thyroid carcinomas. Our previous comparative analyses of the relative distribution of transferrin in benign versus papillary thyroid carcinoma (PTC) tissues highlighted a marked malignancy-associated abundance of the molecule. The aim of the present study was to evaluate whether TfR1/CD71 is also differentially expressed in benign versus malignant thyroid tissues.lld:pubmed
pubmed-article:21323588pubmed:languageenglld:pubmed
pubmed-article:21323588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21323588pubmed:citationSubsetIMlld:pubmed
pubmed-article:21323588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21323588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21323588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21323588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21323588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21323588pubmed:statusMEDLINElld:pubmed
pubmed-article:21323588pubmed:monthMarlld:pubmed
pubmed-article:21323588pubmed:issn1557-9077lld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:MagroGaetanoGlld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:ParentiRosalb...lld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:TorrisiAntoni...lld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:AsioliSofiaSlld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:D'AgataVeliaVlld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:PerrisRoberto...lld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:MucignatMaria...lld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:AmicoPaoloPlld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:VecchioGiada...lld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:CataldoIvanaIlld:pubmed
pubmed-article:21323588pubmed:authorpubmed-author:RecuperoDanie...lld:pubmed
pubmed-article:21323588pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21323588pubmed:volume21lld:pubmed
pubmed-article:21323588pubmed:ownerNLMlld:pubmed
pubmed-article:21323588pubmed:authorsCompleteYlld:pubmed
pubmed-article:21323588pubmed:pagination267-77lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:meshHeadingpubmed-meshheading:21323588...lld:pubmed
pubmed-article:21323588pubmed:year2011lld:pubmed
pubmed-article:21323588pubmed:articleTitleAberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.lld:pubmed
pubmed-article:21323588pubmed:affiliationDepartment G.F. Ingrassia, Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele," Anatomic Pathology, University of Catania, Catania, Italy. g.magro@unict.itlld:pubmed
pubmed-article:21323588pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21323588pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7037entrezgene:pubmedpubmed-article:21323588lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21323588lld:entrezgene